| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Samsara Biocapital Gp, LLC is a 10% Owner at Scholar Rock Holding Corp with holdings across 4 companies. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $541.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | MLYS Mineralys Therapeutics, Inc. | 10% Owner | Buy | 600,000 | $13.50 | $8,100,000.00 | +11.8% | +15.2% | +94.0% | |
| Nov 26, 2024 | NGNE Neurogene Inc. | 10% Owner | Buy | 48,770 | $25.83 | $1,259,622.58 | +0.7% | -38.2% | -21.9% | |
| Feb 12, 2024 | MLYS Mineralys Therapeutics, Inc. | 10% Owner | Buy | 555,555 | $13.50 | $7,499,992.50 | +12.3% | -12.2% | -34.4% | |
| Oct 16, 2023 | SRRK Scholar Rock Holding Corp | 10% Owner | Buy | 2,189,781 | $6.85 | $14,999,999.85 | +47.6% | +92.6% | +245.5% |